Health Condition 1: L088- Other specified local infections of the skin and subcutaneous tissue
Conditions
Interventions
Intervention1: probiotic: These will be given as capsular preparations. Each capsule contains- 5 Billion
CFU
Lactobacillus johnsonii UBLJ-01-3.8
billion cfu
Bifidobacterium breve UBBr-01-0.6
billio
Sponsors
Dr Pratik Gahalaut
Eligibility
Inclusion criteria
Inclusion criteria: Patients above the age of 18 to 59 years with clinical evidence of Dermatophytosis & who are willing to take part in study with written informed consent
Exclusion criteria
Exclusion criteria: 1. Pregnant or lactating women 2. Severe cardiac, pulmonary, gastrointestinal, renal, hepatic, or neurological disease and uncontrolled diabetes mellitus or neoplasia 3. Known hypersensitivity to oral or topical antifungal agents, 4.Treatment with systemic antifungal agents in the previous one month, systemic antibiotics in the previous 2 weeks, corticosteroids or immunosuppressant in the past 6 weeks, or any investigational drug in the previous 3 months. 5. Patients with concomitant any other skin disease. 6. Patients who are not KOH positive at the baseline.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. Biochemical (in serum) IL 6 IL 10 IL 12 TNF alpha IFN gamma NOTimepoint: Baseline and after 12 weeks | — |
Secondary
| Measure | Time frame |
|---|---|
| Clinical Objective assessment by Severity score Subjective VAS scoring by patientTimepoint: Baseline and after 12 weeks | — |
Countries
India
Contacts
Public ContactVishavjot
SRMS Institute of Medical Sciences, Bareilly
Outcome results
None listed